Using Neuromodulation for Migraine

Kristen Sparrow • August 18, 2017

Bioelectronics Company That is Targeting Migraine Treatment Raises $6 Million

July 4, 2017 – Israel-based medical device company Theranica Bio-electronics raised $6 million in Series A financing, which it will use on the regulatory process for its first product, an acute treatment for migraine. The company said its device is in a pivotal study in eight hospitals and clinics in the U.S. and Israel. The company was founded in 2016 to develop wireless neuromodulation approaches. (Globes)